project id: TCGA-LIHC; case submitter id: TCGA-3K-AAZ8; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.71; rna integrity number: 8.8; age at index: 65; days to birth: -24046; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1948; age at diagnosis: 24046; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 396.0; icd 10 code: C22.0; last known disease status: not reported; morphology: 8170/3; primary diagnosis: Hepatocellular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: No; tissue or organ of origin: Liver; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 65; initial weight: 230.0; sample id: bb485b2f-3a35-41e1-81b8-d6b0ba4f8a64; sample submitter id: TCGA-3K-AAZ8-01A; portion id: d7e852ac-3979-4943-ab2d-d6d2b5a3b688; portion submitter id: TCGA-3K-AAZ8-01A-12; slide id: 2fe2a5d5-4e48-4128-bfea-5fdf64ad9765; slide submitter id: TCGA-3K-AAZ8-01A-01-TSA; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 3.0; percent tumor cells: 96.0; percent tumor nuclei: 95.0; section location: TOP;